The conversation discusses the importance of scalp skin barrier health in hairfolliclecycling, suggesting treatments like ceramides or niacinamide to support hairgrowth. It also mentions the use of finasteride for hair loss.
Hair loss treatments are difficult because hairfollicles react differently to hormones and have varying growthcycles. Treatments mentioned include Minoxidil, finasteride, and RU58841.
Hair regrowth from treatments like finasteride, dutasteride, and minoxidil can take several years, with most visible results appearing within 1-2 years and potential improvements continuing up to 10 years. Consistency and patience are crucial for achieving maximum hair thickness, as hair miniaturization and regrowth are gradual processes.
Scalp hydration may influence hairgrowth by affecting the signaling pathways that control the hairgrowthcycle. Users suggest using facial moisturizer, aloe vera, and oils for scalp hydration.
Poor sleep quality may affect hairgrowthcycles by disrupting the body's natural clock and stress hormones. The focus should be on improving sleep to support overall health, including hairgrowth, rather than relying solely on treatments like Minoxidil, finasteride, or RU58841.
A user shared their 6.5-month experience with topical finasteride (2%) and minoxidil (5%), noting initial progress followed by a significant shedding phase. Others in the conversation reassured that shedding is normal and suggested staying consistent with the treatment for potential regrowth.
Cannabis and THC may have mixed effects on hair, with some studies suggesting potential negative impacts on hairgrowth in isolated hairfollicles, but these results are hard to apply to living humans. Treatments like minoxidil and finasteride are commonly used for hair loss, and the effects of cannabis might be neutral or vary based on individual factors.
Orient Bio is developing a PLGA formulated version of Cyclosporine A to stimulate hairgrowth without its immunosuppressant effects. Users discuss various treatments like Clascoterone, PP405, minoxidil, and tacrolimus, expressing hope for new developments and sharing personal experiences with these treatments.
PP405 is a new hair loss treatment in phase 2 trials that may promote hairgrowth by increasing lactate production and activating hairfollicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.
Minoxidil can prevent hairfollicle miniaturization, not just stimulate hairgrowth. Finasteride and dutasteride don't work for everyone, suggesting DHT may not be the sole cause of hair loss; hair loss could be due to multiple factors, including autoimmune conditions.
JW0061 shows superior hairgrowth results compared to existing treatments, with significant increases in hairfollicles. The Wnt/β-catenin pathway is crucial for hairgrowth, and JW0061 activates this pathway effectively.
SCUBE3 and GT20029 are potential treatments for hair loss, with SCUBE3 stimulating hairgrowth and GT20029 protecting against DHT. A combined approach using SCUBE3, finasteride or dutasteride, and later GT20029 could provide a comprehensive treatment for androgenetic alopecia.
RT1640, a combination of cyclosporin A, minoxidil, and RT175, is discussed as a potential treatment for hair regrowth and repigmentation. The unique formulation aims to enhance hairfolliclegrowth and restore hair pigment without the negative side effects of immunosuppressants.
Applying minoxidil and finasteride to the temples won't cause shedding elsewhere. Shedding occurs due to hairfollicles resetting their growthcycle, not the application location.
Finasteride can help extend the hairgrowthcycle and improve hair density, allowing for long hair despite initial shedding. Periodic shedding may occur, but it typically does not affect healthy hair significantly.
New potential hair loss treatment uses molecules from hairy moles to stimulate folliclegrowth. Topical solution requires less frequent application, like Botox injections a few times per year.
The user experienced subtle hairgrowth improvements using finasteride, dutasteride, and minoxidil over nearly three years, with notable progress at the temples. The front hairline shows quicker regrowth cycles, but the vertex and crown remain unchanged.
A recent discovery in hair cloning identified a previously unknown cell type essential for hairfolliclegrowth, which could potentially make lab-grown hair viable if translated to humans. However, skepticism remains due to past delays and the challenges of replicating results in humans and making the process affordable.
Hair loss involves more than just DHT, with genetic factors like TRPS affecting hairfollicles. Treatments such as Amplifica's AMP-601 and AMP-303 target stem cells for potential hairgrowth solutions.
The conversation discusses why DHT (dihydrotestosterone) negatively affects scalp hair but promotes growth elsewhere on the body. Various opinions include genetic predispositions, differences in hairfollicle reactions to DHT, and the potential role of Omega-3 in reducing inflammation and promoting hair health.
Switching milk brands cleared scalp inflammation and other symptoms, but hair shedding continues. The user hopes shedding will stop as haircycles progress.
MCL-1 protein may help maintain hairfollicles in the growth phase and prevent miniaturization. There is interest in experimental treatments like exosomes, peptides, or stem cell serums to upregulate MCL-1 for hair loss, especially for those not using minoxidil or finasteride.
PP405 may promote short-term hairgrowth by pushing follicles into the growth phase, but concerns exist about long-term effects due to lack of rest phases. Users discuss various treatments like finasteride, minoxidil, spironolactone, alfatradiol, and investigational drugs like KX-826 and GT20029 for hair maintenance and regrowth.
Scientists have successfully grown functional hairfollicles in the lab, marking a significant advancement in hair regeneration research. A user shared their personal experience with hair loss treatments, including Minoxidil and Finasteride, and plans to share a detailed protocol for hair restoration.
Hairfollicle stem cells remain in bald individuals, but progenitor cells do not, raising questions about hair regrowth claims by Pelage. PP405 is discussed as a potential treatment, with skepticism about its effectiveness compared to existing treatments like Minoxidil and Finasteride.
Caffeine may promote hairgrowth and potentially inhibit 5-α-reductase activity in hairfollicles, but its effectiveness and systemic impact remain unclear. Users discuss using topical caffeine solutions, with some experiencing no side effects compared to finasteride.
Hairgrowth relies on mechanical forces, not just chemicals, with tissue acting like a motor. Minoxidil and finasteride help, but maintaining tissue elasticity and addressing mechanical issues are essential.
Ultrasound imaging can predict hair shedding and assess hairgrowth stages by analyzing hairfollicle characteristics. The conversation also discusses using ultrasound for personal hair analysis and mentions the potential use of infrared emission for hair treatment.
TDM-105795 showed promising hairgrowth results, with higher efficacy than placebo and minimal side effects. It activates dormant hairfollicle stem cells and may maintain gains without immediate loss, unlike minoxidil.